Fulcrum Therapeutics, Inc. (FULC) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 338.67M | 357.48M | 205.86M | 219.37M | 232.56M | 249.92M | 267.49M | 280.29M | 217.95M | 242.2M | 262.49M | 282.95M |
| Cash & Short-Term Investments | 333.32M | 352.31M | 200.65M | 214.11M | 226.6M | 241.02M | 257.23M | 273.78M | 213.31M | 236.22M | 257.09M | 278.16M |
| Cash Only | 50.26M | 197.53M | 47.08M | 42.59M | 42.18M | 58.21M | 72.63M | 86.7M | 39.95M | 25.56M | 30.08M | 33.97M |
| Short-Term Investments | 283.06M | 154.77M | 153.57M | 171.52M | 184.43M | 182.81M | 184.6M | 187.08M | 173.37M | 210.66M | 227.01M | 244.2M |
| Accounts Receivable | 0 | 1.07M | 934K | 1.33M | 979K | 3.34M | 3.66M | 3.53M | 1.08M | 2.25M | 1.68M | 2.07M |
| Days Sales Outstanding | - | - | - | - | - | - | - | 2.63 | - | 207.45 | 227.21 | 172.38 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.35M | 5.17M | 0 | 0 | 4.97M | 0 | 1.57M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 8.1M | 8.8M | 8.99M | 9.46M | 10.09M | 10.79M | 11.52M | 13.97M | 14.64M | 15.49M | 16.39M | 17.38M |
| Property, Plant & Equipment | 6.35M | 7.07M | 7.79M | 8.25M | 8.88M | 9.58M | 10.24M | 10.77M | 11.45M | 12.39M | 13.31M | 14.3M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | 7.20x | - | 0.07x | 0.05x | 0.06x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2M | 1.09M | 1.09M | 1.09M |
| Other Non-Current Assets | 1.75M | 1.74M | 1.21M | 1.22M | 1.21M | 1.21M | 1.28M | 3.21M | 1.99M | 2.01M | 1.99M | 1.99M |
| Total Assets | 346.77M | 366.28M | 214.86M | 228.84M | 242.65M | 260.72M | 279.01M | 294.26M | 232.59M | 257.69M | 278.88M | 300.33M |
| Asset Turnover | - | - | - | - | - | - | - | 0.30x | - | 0.00x | 0.00x | 0.00x |
| Asset Growth % | 42.91% | 40.49% | -22.99% | -22.23% | 4.33% | 1.17% | 0.05% | -2.02% | -27.57% | 13.68% | 12.54% | 53.83% |
| Total Current Liabilities | 9.86M | 13.05M | 11.63M | 8.98M | 8.1M | 11.04M | 14.51M | 12.7M | 10.69M | 13.68M | 14.07M | 14.8M |
| Accounts Payable | 2.45M | 1.59M | 2.86M | 1.75M | 1.51M | 1.16M | 4.04M | 3.58M | 3.86M | 2.76M | 3.57M | 3.91M |
| Days Payables Outstanding | - | -682.03 | - | 494.13 | - | 648.86 | - | 19.61 | 628.26 | 573.28 | 18.87 | 19.6 |
| Short-Term Debt | 2.46M | 2.4M | 0 | 0 | 2.24M | 0 | 0 | 0 | 2.03M | 2.19M | 2.35M | 2.51M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 334K | 513K |
| Other Current Liabilities | 4.95M | 9.05M | 6.43M | 2.43M | 4.35M | 463K | 400K | 4.31M | 3.19M | 4.01M | 3.79M | 4.94M |
| Current Ratio | 34.33x | 27.40x | 17.70x | 24.42x | 28.71x | 22.63x | 18.44x | 22.07x | 20.38x | 17.71x | 18.65x | 19.11x |
| Quick Ratio | 34.33x | 27.40x | 17.70x | 24.42x | 28.71x | 22.63x | 18.44x | 22.07x | 20.38x | 17.71x | 18.65x | 19.11x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.6M | 4.24M | 4.86M | 5.47M | 6.06M | 6.64M | 7.21M | 7.77M | 8.3M | 8.83M | 9.34M | 10.1M |
| Long-Term Debt | 3.41M | 4.04M | 0 | 0 | 5.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 4.66M | 5.28M | 0 | 6.44M | 7.01M | 7.57M | 8.11M | 8.63M | 9.14M | 9.65M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 197K | 197K | 197K | 197K | 197K | 197K | 197K | 197K | 197K | 0 | 197K | 447K |
| Total Liabilities | 13.47M | 17.28M | 16.49M | 14.46M | 14.16M | 17.68M | 21.72M | 20.47M | 19M | 22.5M | 23.42M | 24.9M |
| Total Debt | 5.87M | 6.44M | 7.01M | 7.57M | 8.11M | 8.63M | 9.14M | 9.65M | 10.14M | 10.82M | 11.49M | 12.16M |
| Net Debt | -44.39M | -191.09M | -40.07M | -35.02M | -34.07M | -49.58M | -63.48M | -77.05M | -29.81M | -14.74M | -18.59M | -21.81M |
| Debt / Equity | 0.02x | 0.02x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.05x | 0.05x | 0.04x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - | 0.18x | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -1.46x | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 333.3M | 349M | 198.37M | 214.38M | 228.49M | 243.03M | 257.29M | 273.79M | 213.59M | 235.19M | 255.46M | 275.43M |
| Equity Growth % | 45.87% | 43.6% | -22.9% | -21.7% | 6.97% | 3.33% | 0.72% | -0.59% | -27.9% | 18.22% | 15.38% | 71.33% |
| Book Value per Share | 4.37 | 5.51 | 3.17 | 3.43 | 3.66 | 4.50 | 4.12 | 4.31 | 3.45 | 3.80 | 4.13 | 4.46 |
| Total Shareholders' Equity | 333.3M | 349M | 198.37M | 214.38M | 228.49M | 243.03M | 257.29M | 273.79M | 213.59M | 235.19M | 255.46M | 275.43M |
| Common Stock | 67K | 67K | 54K | 54K | 54K | 54K | 54K | 62K | 62K | 62K | 62K | 62K |
| Retained Earnings | -613.17M | -594.28M | -573.94M | -554.35M | -537.05M | -519.4M | -502.83M | -481.13M | -536.54M | -509.67M | -484.92M | -460.9M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -513K | 0 | 241K | 82K | 0 | 130K | 379K | -366K | -434K | -136K | -886K | -1.2M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |